S100A10, a novel biomarker in pancreatic ductal adenocarcinoma

Pancreatic cancer is arguably the deadliest cancer type. The efficacy of current therapies is often hindered by the inability to predict patient outcome. As such, the development of tools for early detection and risk prediction is key for improving outcome and quality of life. Here, we introduce the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Oncol
Glavni autori: Bydoun, Moamen, Sterea, Andra, Liptay, Henry, Uzans, Andrea, Huang, Weei‐Yuarn, Rodrigues, Gloria J., Weaver, Ian C.G., Gu, Hong, Waisman, David M.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6210040/
https://ncbi.nlm.nih.gov/pubmed/30009399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12356
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items